$588.23
0.6%
Price vs. AI Score (Last 150 days)
Data gathered: December 7
Data gathered: December 7
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 730 0.4% |
|
| Sentiment | 82 -4.7% |
|
| Webpage traffic | 924,000 -6.2% |
|
| Employee Rating | 81 0% |
|
| Google Adspend | $3,919 -6.4% |
|
| Google Trends | -100% |
|
| Linkedin Employees | 41,333 N/A |
|
| Patents | 436 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 355 63.6% |
|
| Facebook followers | 242,252 0.2% |
|
| Stocktwits Mentions | 46 -37.8% |
|
| Stocktwits Subscribers | 14,711 0% |
|
| Twitter Followers | 141,856 0% |
|
| Instagram Followers | 31,087 0% |
|
| News Mentions | 2 0% |
|
| Reddit Mentions | 2 -33.3% |
|
| ESG | 69 0% |
|
| Business outlook | 84 0% |
|
In the news
 |
Eli Lilly & Co. stock outperforms market on strong trading dayDecember 6 - MarketWatch |
 |
CNBC Daily Open: Buzz words of the day — tech, AI, cryptoDecember 5 - CNBC |
 |
5 Things to Know Before Markets OpenDecember 5 - Yahoo |
30 Stocks shunned by hedge and mutual funds - GSDecember 5 - Seeking Alpha |
|
Top 30 stocks with highest hedge fund + mutual fund short positions – GSDecember 5 - Seeking Alpha |
|
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different PrioritiesDecember 5 - Benzinga |
|
About Eli Lilly and Company
Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
| Price | $588.23 |
| Target Price | Sign up |
| Market Cap | $558B |
| Dividend Yield | 0.0077 |
| Industry | Drug Manufacturers |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$155.65 0.6% | 47 |
 |
PfizerPFE |
$28.69 0.3% | 51 |
 |
AstrazenecaAZN |
$63.54 0.3% | 64 |
 |
AbbVieABBV |
$147.97 0.7% | 52 |
 |
TherapeuticsMDTXMD |
$2.24 2.2% | 33 |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 9.5B | 3.55B | 5.95B | -57M | 6.4B |
| Q2 '23 | 8.31B | 3.62B | 4.69B | 1.76B | 2.32B |
| Q1 '23 | 6.96B | 3.26B | 3.7B | 1.34B | 1.7B |
| Q4 '22 | 7.3B | 3.72B | 3.59B | 1.94B | 2.39B |
| Q3 '22 | 6.94B | 3.31B | 3.63B | 1.45B | 2.4B |
Insider Transactions
| Zakrowski Donald A filed to sell 4,708 shares at $571.1. November 6 '23 |
| LILLY ENDOWMENT INC filed to sell 99,768,810 shares at $607.7. October 12 '23 |
| Weems Alonzo filed to sell 7,760 shares at $591. September 13 '23 |
| LILLY ENDOWMENT INC filed to sell 99,983,810 shares at $575.4. September 8 '23 |
| LILLY ENDOWMENT INC filed to sell 100,193,810 shares at $557.2. September 1 '23 |
Read more about Eli Lilly and Company and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, instagram followers, news mentions, reddit mentions, esg, business outlook.